{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T21:09:07Z","timestamp":1794517747091,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":36,"publisher":"Springer New York","isbn-type":[{"value":"9781493936595","type":"print"},{"value":"9781493936618","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3661-8_10","type":"book-chapter","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T06:04:12Z","timestamp":1462428252000},"page":"153-175","source":"Crossref","is-referenced-by-count":19,"title":["Mouse Models of Type 2 Diabetes Mellitus in Drug Discovery"],"prefix":"10.1007","author":[{"given":"Helene","family":"Baribault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0092-8674(01)00239-2","volume":"104","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR (2001) New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517\u2013529","journal-title":"Cell"},{"key":"10_CR2","unstructured":"Prevention CfDCa (2014) National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States. U. S. Department of Health and Human Services, Atlanta, GA"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJM197608192950804","volume":"295","author":"RJ Koenig","year":"1976","unstructured":"Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A (1976) Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 295:417\u2013420","journal-title":"N Engl J Med"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"602","DOI":"10.7326\/0003-4819-154-9-201105030-00336","volume":"154","author":"WL Bennett","year":"2011","unstructured":"Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R et al (2011) Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 154:602\u2013613","journal-title":"Ann Intern Med"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al (2012) Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364\u20131379","journal-title":"Diabetes Care"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M et al (2013) PPARgamma signaling and metabolism: the good, the bad and the future. Nat Med 19:557\u2013566","journal-title":"Nat Med"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/dmrr.783","volume":"24","author":"P Raskin","year":"2008","unstructured":"Raskin P (2008) Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes. Diabetes Metab Res Rev 24:3\u201313","journal-title":"Diabetes Metab Res Rev"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4239\/wjd.v5.i5.636","volume":"5","author":"GH Tomkin","year":"2014","unstructured":"Tomkin GH (2014) Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors. World J Diabetes 5:636\u2013650","journal-title":"World J Diabetes"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"212264","DOI":"10.7573\/dic.212264","volume":"3","author":"EM Vivian","year":"2014","unstructured":"Vivian EM (2014) Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of antidiabetic agents. Drugs Context 3:212264","journal-title":"Drugs Context"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jama.2014.10706","volume":"312","author":"N Puzziferri","year":"2014","unstructured":"Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH (2014) Long-term follow-up after bariatric surgery: a systematic review. JAMA 312:934\u2013942","journal-title":"JAMA"},{"key":"10_CR11","doi-asserted-by":"crossref","unstructured":"Sanghera DK, Blackett PR (2012) Type 2 diabetes genetics: beyond GWAS. J Diabetes Metab 3:6948-6971","DOI":"10.4172\/2155-6156.1000198"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s11605-013-2188-3","volume":"17","author":"H Yu","year":"2013","unstructured":"Yu H, Zheng X, Zhang Z (2013) Mechanism of Roux-en-Y gastric bypass treatment for type 2 diabetes in rats. J Gastrointest Surg 17:1073\u20131083","journal-title":"J Gastrointest Surg"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1517\/14728222.2014.968128","volume":"18","author":"H Baribault","year":"2014","unstructured":"Baribault H, Majeti JZ, Ge H, Wang J, Xiong Y, Gardner J et al (2014) Advancing therapeutic discovery through phenotypic screening of the extracellular proteome using hydrodynamic intravascular injection. Expert Opin Ther Targets 18:1253\u20131264","journal-title":"Expert Opin Ther Targets"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1210\/en.2012-1211","volume":"153","author":"MM Veniant","year":"2012","unstructured":"Veniant MM, Komorowski R, Chen P, Stanislaus S, Winters K, Hager T et al (2012) Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys. Endocrinology 153:4192\u20134203","journal-title":"Endocrinology"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"162ra53","DOI":"10.1126\/scitranslmed.3004690","volume":"4","author":"IN Foltz","year":"2012","unstructured":"Foltz IN, Hu S, King C, Wu X, Yang C, Wang W et al (2012) Treating diabetes and obesity with an FGF21-mimetic antibody activating the betaKlotho\/FGFR1c receptor complex. Sci Transl Med 4:162ra53","journal-title":"Sci Transl Med"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","volume":"18","author":"G Gaich","year":"2013","unstructured":"Gaich G, Chien JY, Fu H, Glass LC, Deeg MA, Holland WL et al (2013) The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab 18:333\u2013340","journal-title":"Cell Metab"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1194\/jlr.M027094","volume":"54","author":"X Wu","year":"2013","unstructured":"Wu X, Ge H, Baribault H, Gupte J, Weiszmann J, Lemon B et al (2013) Dual actions of fibroblast growth factor 19 on lipid metabolism. J Lipid Res 54:325\u2013332","journal-title":"J Lipid Res"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"14158","DOI":"10.1073\/pnas.1009427107","volume":"107","author":"X Wu","year":"2010","unstructured":"Wu X, Ge H, Lemon B, Vonderfecht S, Baribault H, Weiszmann J et al (2010) Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19). Proc Natl Acad Sci U S A 107:14158\u201314163","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"1241214","DOI":"10.1126\/science.1241214","volume":"341","author":"VK Ridaura","year":"2013","unstructured":"Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL et al (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341:1241214","journal-title":"Science"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/cpt.146","volume":"98","author":"S Srinivasan","year":"2015","unstructured":"Srinivasan S, Florez JC (2015) Therapeutic challenges in diabetes prevention: we have not found the \"Exercise Pill\". Clin Pharmacol Ther 98:162\u2013169","journal-title":"Clin Pharmacol Ther"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.tem.2013.12.004","volume":"25","author":"KL Townsend","year":"2014","unstructured":"Townsend KL, Tseng YH (2014) Brown fat fuel utilization and thermogenesis. Trends Endocrinol Metab 25:168\u2013177","journal-title":"Trends Endocrinol Metab"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/ddrr.20","volume":"14","author":"JC Halford","year":"2008","unstructured":"Halford JC, Harrold JA (2008) Neuropharmacology of human appetite expression. Dev Disabil Res Rev 14:158\u2013164","journal-title":"Dev Disabil Res Rev"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.yfrne.2009.10.003","volume":"31","author":"S Fulton","year":"2010","unstructured":"Fulton S (2010) Appetite and reward. Front Neuroendocrinol 31:85\u2013103","journal-title":"Front Neuroendocrinol"},{"key":"10_CR24","unstructured":"Yeadon J (2015) Choosing among type II diabetes mouse models. The Jackson Laboratory. https:\/\/new.jax.org\/news-and-insights\/jax-blog\/2015\/july\/choosing-among-type-ii-diabetes-mouse-models#"},{"key":"10_CR25","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1517\/14712598.2011.619974","volume":"11","author":"CS Tam","year":"2011","unstructured":"Tam CS, Lecoultre V, Ravussin E (2011) Novel strategy for the use of leptin for obesity therapy. Expert Opin Biol Ther 11:1677\u20131685","journal-title":"Expert Opin Biol Ther"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1152\/japplphysiol.01077.2006","volume":"102","author":"KL Svenson","year":"2007","unstructured":"Svenson KL, Von Smith R, Magnani PA, Suetin HR, Paigen B, Naggert JK et al (2007) Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations. J Appl Physiol (1985) 102:2369\u20132378","journal-title":"J Appl Physiol (1985)"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/sj.ijo.0803110","volume":"30","author":"J Alexander","year":"2006","unstructured":"Alexander J, Chang GQ, Dourmashkin JT, Leibowitz SF (2006) Distinct phenotypes of obesity-prone AKR\/J, DBA2J and C57BL\/6J mice compared to control strains. Int J Obes (Lond) 30:50\u201359","journal-title":"Int J Obes (Lond)"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1210\/er.2006-0035","volume":"28","author":"SM Clee","year":"2007","unstructured":"Clee SM, Attie AD (2007) The genetic landscape of type 2 diabetes in mice. Endocr Rev 28:48\u201383","journal-title":"Endocr Rev"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1538\/expanim.56.263","volume":"56","author":"S Nishikawa","year":"2007","unstructured":"Nishikawa S, Yasoshima A, Doi K, Nakayama H, Uetsuka K (2007) Involvement of sex, strain and age factors in high fat diet-induced obesity in C57BL\/6J and BALB\/cA mice. Exp Anim 56:263\u2013272","journal-title":"Exp Anim"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0026-0495(98)90027-0","volume":"47","author":"J Luo","year":"1998","unstructured":"Luo J, Quan J, Tsai J, Hobensack CK, Sullivan C, Hector R et al (1998) Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metab Clin Exp 47:663\u2013668","journal-title":"Metab Clin Exp"},{"issue":"11","key":"10_CR31","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1517\/14728222.2014.968128","volume":"18","author":"H Baribault","year":"2014","unstructured":"Baribault H et al (2014) Advancing therapeutic discovery through phenotypic screening of the extracellular proteome using hydrodynamic intravascular injection. Expert Opin Ther Targets 18(11):1253\u20131264","journal-title":"Expert Opin Ther Targets"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.2337\/db08-0553","volume":"57","author":"M Kebede","year":"2008","unstructured":"Kebede M, Alquier T, Latour MG, Semache M, Tremblay C, Poitout V (2008) The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding. Diabetes 57:2432\u20132437","journal-title":"Diabetes"},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1152\/physiolgenomics.00033.2008","volume":"35","author":"DA Buchner","year":"2008","unstructured":"Buchner DA, Burrage LC, Hill AE, Yazbek SN, O'Brien WE, Croniger CM et al (2008) Resistance to diet-induced obesity in mice with a single substituted chromosome. Physiol Genomics 35:116\u2013122","journal-title":"Physiol Genomics"},{"key":"10_CR34","doi-asserted-by":"publisher","first-page":"E454","DOI":"10.1152\/ajpendo.00470.2002","volume":"285","author":"R Brommage","year":"2003","unstructured":"Brommage R (2003) Validation and calibration of DEXA body composition in mice. Am J Physiol Endocrinol Metab 285:E454\u2013E459","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"E703","DOI":"10.1152\/ajpendo.00072.2001","volume":"282","author":"FM Gregoire","year":"2002","unstructured":"Gregoire FM, Zhang Q, Smith SJ, Tong C, Ross D, Lopez H et al (2002) Diet-induced obesity and hepatic gene expression alterations in C57BL\/6J and ICAM-1-deficient mice. Am J Physiol Endocrinol Metab 282:E703\u2013E713","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/oby.2004.20","volume":"12","author":"FC Tinsley","year":"2004","unstructured":"Tinsley FC, Taicher GZ, Heiman ML (2004) Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes Res 12:150\u2013160","journal-title":"Obes Res"}],"container-title":["Methods in Molecular Biology","Mouse Models for Drug Discovery"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3661-8_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T20:54:11Z","timestamp":1547844851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3661-8_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493936595","9781493936618"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3661-8_10","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-3661-8","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}